《大行報告》瑞信上調神華(01088.HK)目標價至27.6元 評級「跑贏大市」
瑞信上調神華(01088.HK)目標價,由27元上調至27.6元,評級「跑贏大市」。
瑞信指,神華首季淨利潤勝預期,將2022年至2024年的盈利預測分別提高9.8%/5.7%/1.9%,以反映更高的煤炭和電力價格假設。同時預計低利潤的第三方煤炭的下降將有助於提高煤炭分部的整體盈利能力。
該行相信,長期合同煤價格提高和允許燃煤電價在基準價上波動不超過20%,將爲神華的盈利能力提供支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.